Professor Kylie O’Brien shares her insights on the evolving medicinal cannabis landscape — from evidence gaps and ongoing misconceptions to regulatory challenges and emerging research.

As a leading scientific expert and recent co-author of Medicinal Cannabis in Women’s Health, she offers a clear, grounded perspective on what the industry needs next and how clinical practice can better align with the science.

Get to know Adam Isaac Miller, one of Australia’s most influential and longstanding voices in the medicinal cannabis landscape. With nearly eleven years of experience spanning clinical, regulatory, commercial, and policy domains.

Unpack the experiences that have defined his journey — from his deeply personal introduction to cannabis, to the milestones that have shaped his career, the lessons he’s learned advising stakeholders across the ecosystem, and the honest concerns and hopes he holds for the future of the industry.

Medicinal cannabis in Australia is rapidly evolving — where what was once a niche market is now a significant part of modern healthcare. For businesses navigating this landscape, understanding these dual pressures is key to thriving in this fast-paced and dynamic environment.

Get to know Sharlene Mavor,  medical scientist specialising in medicinal cannabis research and the Co-Founder and Managing Director of Medicinal Cannabis Research Australia (MCRA). Sharlene is a trailblazer within the industry in her own right and for this blog post, we’ve got her to answer some informative questions about her journey, her opinion on the industry, and what brands & businesses can learn from it.

Peak a look behind the scenes with our founders Lisa Varley & Tahlia Bavadra discussing their journey into the medicinal cannabis space, industry insights & their vision of the market.

Explore the key rules from governing regulators as it relates to advertising within the medicinal cannabis space to, clarify what clinics and brands can and cannot say, alongside safer strategies to build awareness without risking compliance.

Registered nurses with appropriate training and experience will be able to prescribe medicinal cannabis under a collaborative prescribing model. In this post, we explore how this change brings unprecedented opportunity and responsibility.

In the latest addition to our Market Insights series that explores the Australian medicinal cannabis space, we look into patient demographics and how patients access plant-based medicines.

We sat down with industry trailblazer, Irena Katz of We Are Lux, to discuss her journey within the medicinal cannabis industry as a qualified naturopath and passionate cannabis advocate. In this post, we explore how Irena's personal experience, purpose, and bold vision has made her a strong patient advocate and industry innovator — and how these qualities have also helped shape her store We Are Lux.

For businesses looking to enter or maximise their presence within the medicinal cannabis market, understanding the evolving prescriber landscape and access pathways is crucial to navigate this dynamic market effectively.

Since its legalisation for therapeutic use, Australia’s medicinal cannabis industry has rapidly evolved, marked by complex regulatory changes and a growing infrastructure — making it essential for industry stakeholders to understand the journey of legalisation, its impact on Australian patients, and the diverse ecosystem of stakeholders working to expand access and challenge the lingering stigma surrounding medicinal cannabis.

For healthcare practitioners prescribing or dispensing medicinal cannabis in Australia, it’s essential to understand the varying regulations that can impact patient outcomes — including dispensing substitution policies for these medications.